I-0.2% DexamethameThasone Sodium phosphate inaliti
Inketho ye-Pharmacological
Iziphumo ze-DexamethaThasone zifana neyo ye-hydrocorisone, kodwa impembelelo ide, ixesha elisebenzayo lide, kwaye iziphumo ebezingalindelekanga zincinci. Iziphumo zeGluconegenesis kunye neGluconeogenesis ngamaxesha angama-25 ze-hydrocorisone, ngelixa ifuthe le-sodium yokugcina kunye nokuvelela kwe-potassium incinci kune-hydrocomer. Ukuthintela i-pitture-adrenortical axis. Ukongeza kwezi ziphumo zilapha ngasentla, le mveliso inokusetyenziselwa ukungeniswa kwabasebenzi kwiidama eziziswe ngaxeshanye, kodwa inokunyusa umgangatho we-placenta egciniweyo, kwaye ibuyise i-uteris kwimeko yesiqhelo.
Inaliti ye-intramuscular ibonise isiphumo esikhawulezayo kwizinja, kunye ne-Piak Gxixa kwiiyure ezingama-0,5 kunye nesiqingatha sobomi bama-48 eeyure ezingama-48, ikakhulu ikhutshiwe kwimigca kunye nomchamo kunye nomchamo.

Iphawu
I-0.2% Dexamethamethasson inalitiisetyenziselwa izifo ezosulela kakhulu, ezinje nge-sepsis eyahlukeneyo, i-pinonia enetyhefu, i-discillary enetyhefu, i-peritonitis, kunye ne-PlestPartur
Unyango oluhlawulelwayo lweMetriti ye-metriti. Unyango lwezifo ze-allergic, ezinjenge-allergic Rhinitis, i-Urticaria, i-allergic yokuphefumla, i-ablegegic yokuphefumla, igqabi lokuvalwa kwenyawo, igqabi le-AllGema, njlgic Eczema, njl.; unyango olothusayo olubangelwa zizizathu ezahlukeneyo; IKetomia kunye ne-ovine toxemia yokukhulelwa, njl.; kunye nokungenisa ukuhanjiswa ngaxeshanye kwiinkomo kunye neegusha.
Umthamo noLawulo
Inaliti ye-intramuscular kunye nenaliti: idosi yemihla ngemihla, 1:25 ~ 2: 5ml ngamahashe; 2: 5 ~ 10ml ngeenkomo; 2 ~ 6ml ngenxa yegusha nehagu; 0: 0625 ~ 0: 5ml ngenxa yezinja neekati. Inaliti ye-Intra-inaliti: 1 ~ 5ml ngamahashe neenkomo.
Iziphumo ezibi
(1) I-sodium eyomeleleyo kunye nokugcinwa kwamanzi kunye ne-potassium.
(2) Inefuthe elinamandla lonqulo.
(3) Iidosi ezinkulu ekukhulelweni kwasezantsi zinokubangela isisu.
. enokuthi ifune ukupheliswa kwechiza.
. Unyango ixesha elide ngeedosi eziphezulu lunokubangela ukuba i-cusitymome syndrome.
Ukulumkela
(1) Ngokuqonda ngokungqongqo uphawu lokuthintela ukuphathwa gadalala.
.
.
.
.
Ixesha lokurhoxa
Iintsuku ezingama-21 zeenkomo, iigusha neehagu ngexesha lokuphumla; Iiyure ezingama-72 zexesha lokushiya.
Ukugcinwa
Gcina izitya ezitywiniweyo, ezikhuselweyo ukusuka ekukhanyeni.
I-Hebei Veyolong Pharmaceutical Co., i-LTD, ibekwe kwiSixeko saseShijiazhuang, kwiPhondo laseHebei, iChina, ecaleni kwengxowa ye-Beijing. Uyishishini elikhulu eliqinisekisiweyo le-GMP le-GEMP ye-GEMP, ene-R & D, ukuvelisa kunye nentengiso ye-Veterinal Apis, amalungiselelo, i-PREPEDED yezongezo. Njengeziko lobugcisa lePhondo, iVeyong iseke inkqubo ye-R & D yeS System yeZiyobisi eziNtsha zeZilwanyana, kwaye zisekelezwe kwishishini lezonyango lwezilwanyana, kukho iingcali ezingama-65 zezobugcisa. IVeyong ineziseko zambini zemveliso: Shijiazhuang kunye ne-Shijiazduang Isiseko esinendawo ye-78,706 M2, i-APPINECTINE YEMIQATHANGO YOKUGQIBELA, I-APIALITINE YOKUGQIBELA I-IYIMATION, i-APIALITCINE YEMIQATHANGO YOKUGQIBELA, INDAWO YOKUGQIBELA, I-PREPE, Izitshabalalisi kunye nentsholongwane, i-ECT. IVeyong ibonelela nge-APIs, amalungiselelo angaphezu kwe-100 yeelebheli, kunye nenkonzo ye-OEM ye-ODM.
IVeyong inamathela ngokubaluleke kakhulu kulawulo lwe-EHS (engqongileyo, iMpilo noKhuseleko), kwaye bafumana i-ISO14001 kunye nezatifikethi ze-OHSAs18001. IVeyong idweliswe kumashishini asahlumayo kwiPhondo kwiPhondo laseHebei kwaye unokuqinisekisa ukuqhubeka kweemveliso.
IVeyong iseke inkqubo epheleleyo yolawulo lomgangatho, yafumana isatifikethi se-ISO9001, iSiqinisekiso se-China E-Australia APVMA GMP IVeyong ineqela elinobuchule, ukuthengisa kunye nenkonzo yezobuchwephesha, inkampani yethu ifumene ukuthembela kunye nenkxaso yabathengi abaninzi ngoMgangatho wemveliso ebalaseleyo, inkonzo yasemva kwentengiso kunye nezenzululwazi. IVeyong yenze intsebenziswano yexesha elide yamashishini amashishini amaninzi amayeza e-EURRERMEEDICATION ezikhutshelwe ngaphandle eYurophu, uMzantsi Merika, eMbindi Mpuma, e-Afrika, iAfrika, njl njl.